Navigation Links
ViroPharma Announces Securities Repurchase Program
Date:3/9/2011

ocin® (Vancomycin Hydrochloride Capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx).  ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile infection.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking StatementsCertain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. There can be no assurance that we will be successful in enhancing shareholder value, that the future prospects of our existing business will derive ongoing financial strength, or that we will be successful in completing future business development transactions. These factors, and other factors, including, but not limited to those described in our annual report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibil
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ViroPharma to Participate in Two March Healthcare Conferences
2. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
3. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
4. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
5. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
6. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
7. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
8. ViroPharma To Participate in Two September Healthcare Investor Conferences
9. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
10. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
11. ViroPharma to Participate in Two June Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
(Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
(Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... growing medical-surgical supply costs as reimbursements shrink and healthcare ... spending immediately—and GHX is providing a list of what ... it. The healthcare technology company released its list at ... focus on documented opportunities for cutting what has become ...
... June 27, 2011 Auxogyn, Inc., a privately held ... announced that the U.S. Patent and Trademark Office (USPTO) ... the assessment of embryo viability during in vitro ... viability assessment (Eeva™) System. "This patent ...
Cached Medicine Technology:Top 10 Ways to Cut Medical-Surgical Supply Spending Now 2Top 10 Ways to Cut Medical-Surgical Supply Spending Now 3Auxogyn Announces Issuance of Key Patent Covering Predictive Embryo Assessment Parameters for In Vitro Fertilization 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Carinsurancesavings.biz has released ... accidental death and dismemberment insurance . , Purchasing an ... can be very advantageous. This type of rider provides benefits ... dismemberment can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... 22, 2015 Four years since the release of ... coincided with the marriage of Avasa & Matthew Love – the ... is scheduled for release through White Swan Records on February 24, ... is a sacred path available to all of us to walk ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... compound that gives curry powder its yellow/orange color, may inhibit ... neck cancer who continue to smoke. In a paper ... and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO ... head and neck squamous cell carcinoma (HNSCC) growths. The study ...
... CA Patients who suffer from chronic rhinosinusitis (CRS) ... asthma, hypertension, and arthritis. In a paper ... Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & ... records of 1,970,695 patients to determine whether there was ...
... million babies are born preterm, almost 10 percent of total ... estimated 13 million infants worldwide are born premature each year ... first month of life, according to a report released Sunday. ... and for 28 percent of newborn deaths, the data ...
... ... Day , ... Africa (Vocus) October 4, 2009 -- Four-year-old Celine was born with congenital cataracts in both ... afford the $180 (US) for surgery for each eye, plus the money required for hospital ...
... Oct. 3 Mercedes-Benz donates an R320 BlueTEC clean ... Hope & Healing in Lewiston, Maine during the inaugural ... in the safety and comfort of transporting those receiving ... , The Patrick Dempsey Center for Cancer Hope & ...
... O,Brien, president of Catholics for Choice, issued the following statement ... Conference of Catholic Bishops holds its annual Respect Life Sunday. ... bishops to also respect the truth. A recent publication by ... recent polls on healthcare reform prove that the bishops, desire ...
Cached Medicine News:Health News:1 Million 'Preemie' Babies Die Each Year: Report 2Health News:1 Million 'Preemie' Babies Die Each Year: Report 3Health News:Mercy Ships Surgeon Addresses Blindness Through Sutureless Technique 2Health News:Mercy Ships Surgeon Addresses Blindness Through Sutureless Technique 3Health News:Mercy Ships Surgeon Addresses Blindness Through Sutureless Technique 4Health News:Mercedes-Benz Gives to a McDreamy Cause 2Health News:Mercedes-Benz Gives to a McDreamy Cause 3Health News:Mercedes-Benz Gives to a McDreamy Cause 4Health News:Respect Life and the Truth on Respect Life Sunday 2Health News:Respect Life and the Truth on Respect Life Sunday 3
... is a rapid and accurate bedside test for ... the diagnosis and assessment of patients with suspected ... speed and accuracy profit from a test ... = 12 minutes. In emergency departments Point of ...
Intermittent catheter...
... dimension in vitreoretinal surgery. ,By using ... purified perfluoro-n-octane, you can greatly expand ... for managing retinal detachments complicated by ... trauma. , ,Certified to be >99.9 ...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions....
Medicine Products: